An analysis of thoracic and abdominal tumour motion for stereotactic body radiotherapy patients was performed using more than 70 h of tumour motion estimated from the correlation between the external and internal motion for 143 treatment fractions in 42 patients. The tumour sites included lungs (30 patients) and retroperitoneum (12 patients). The overall mean respiratory-induced peakto-trough distance was 0.48 cm, with individual treatment fraction means ranging from 0.02 to 1.44 cm. The overall mean respiratory period was 3.8 s, with individual treatment fraction means ranging from 2.2 to 6.4 s. In 57 treatment fractions (40%), the mean respiratory-induced peak-to-trough distance was greater than 0.5 cm. In general, tumour motion was predominantly superior-inferior (60% of all the treatment fractions), while anterior-posterior and left-right motion were 22% and 18%, respectively. The motion was predominantly linear, and the overall mean of the first principal component was 94%. However, for motion magnitude, direction and linearity, large variations were observed from patient to patient, fraction to fraction and cycle to cycle.
new and more promising techniques with the advent of image-guided radiotherapy. Given that the success of these techniques depends on precisely localizing the tumour, an accurate characterization of tumour motion is important during imaging and delivery of radiotherapy.
Many studies show that respiratory tumour motion can be up to 2-3 cm, and it varies with intra-and inter-fractional motion. Both the AAPM Task Group 76 report (Keall et al 2006) and a study by Langen and Jones (2001) summarize tumour motion data in the literature. Although the extent and degree of wide variations in motion were acknowledged in these reports, no consensus was apparent regarding respiratory tumour motion management.
Tumour motion data for a large population of patients over a long period of time have not yet been published. In this study, the tumour motion data estimated from the correlation between the external and internal motion for 143 treatment fractions in 42 patients over time periods corresponding to stereotactic body radiotherapy were used. The aim of this work was to analyse thoracic and abdominal tumour motion for a large patient population over an extended period of time.
Materials and methods
This study was divided into three main tasks. First, a database of patient tumour motion was created from input tracking system motion data; second, the tumour motion data were separated into individual respiratory cycles; third, patient respiratory tumour motion was analysed.
Creation of a database of patient tumour motion
2.1.1. Tracking system motion data. Tumour motion data from 143 treatment fractions for 42 thoracic and abdominal cancer patients treated with the Cyberknife Synchrony (G3 System with delivery software version 6.2.3, Accuray Incorporated, Sunnyvale, CA) in Georgetown University Hospital from July 2005 to January 2006 were used in this study. The tumour locations were lungs (30 patients) and retroperitoneum (12 patients) with one to seven treatment fractions for each patient. The use of the data for research purposes was approved by the Georgetown Institutional Review Board (IRB-2005-309) . Synchrony is a subsystem of respiratory tumour tracking in the Cyberknife system (Adler et al 1997 , Murphy et al 2000 , Schweikard et al 2000 , Murphy 2004 , Dieterich 2005 , Seppenwoolde et al 2007 . In order to compensate for tumour motion, the tracking system estimates internal tumour positions by a correlation between the external patient motion and internal fiducial locations, as well as by a prediction algorithm. For the external patient motion, charge-coupled device (CCD) cameras are used to monitor the multiple light emitting diodes (LEDs) on the patient's chest and abdomen at 32 frames per second. For the internal fiducial locations, two orthogonal diagnostic x-ray systems monitor the implanted markers periodically (e.g., every 30 s or every two beams). The patient tumour motion data used in this study were derived from the correlation model and recorded at 25 Hz by the tracking system. The data contained patient four-dimensional (4D) tumour motion information (3D positions of the tumour versus time) with the format of t:x y z, where t is time in seconds and x, y and z are tumour positions estimated from the correlation model in millimetres (mm). The system accuracy is on the order of 0.5 mm with the uncertainty of 0.3 mm for an end-to-end test on a motion platform, which is the difference between the centre of the planned dose distribution and that of the delivered dose distribution measured by a film (Wong et al 2007) . The technical tracking accuracy is much better (i.e. on the order of 0.6 mm), while fluctuations in the correlation model on the timescale of minutes add much more uncertainty clinically. Typically, the correlation model is rebuilt if an error is 3 mm or more for two images in a row.
It is important to note that the tumour motion analysed in this study is not actual but estimated from the correlation model of the tracking system that is based on periodic stereoscopic x-ray images. The uncertainty of the tracking system motion data was assessed by estimation errors of the correlation model, which the Synchrony system recorded every time two orthogonal x-ray images were acquired and internal fiducial locations were measured. The vector error for each internal fiducial is quantified. The mean and standard deviation (SD) of 3D positional estimation root-mean-square (RMS) errors of the tracking system over 143 treatment fractions was 1.5 ± 0.8 mm. The estimation errors could be due to inaccuracy of the correlation models of the tracking system, or temporal variations in the internal/external correlation model between measurements (Murphy 2004 , Korreman et al 2008 , Nishioka et al 2008 . The uncertainty obtained for the current data set (1.5 ± 0.8 mm) is consistent with the values published by Seppenwoolde et al (2007) , who simulated the Synchrony method using respiratory and orthogonal fluoroscopic measured data in an eight-patient study. They concluded from their data that the systematic error of the position estimation was less than 1 mm for all patients and the mean 3D error was less than 2 mm for over 80% of the time.
Creation of a database.
The tracking system motion data included portions with either no motion or significantly large motion, gaps or spikes that might be from sources other than tumour motion (explained in detail in section 2.1.3). These data were processed to extract the estimated tumour motion from the tracking system motion data and subsequently, the longest single contiguous data set was created according to the criteria for each of 143 treatment fractions. Aside from tumour motion, other possible sources of motion included the motion of a patient or a couch, fiducial mistracking or non-tracking, all of which led to stopping treatment and/or rebuilding or resetting the correlation model, and the learning time of the internal tumour position estimator.
Criteria to create a database.
Each of the tracking system motion data was visually inspected to identify possible areas of exclusion and to select the longest single contiguous data set among the remaining data. The data exclusion criteria were as follows.
(1) Data points showing no motion, which may indicate that the treatment was stopped or the correlation was reset (figure 1(a)). (2) Significantly large motion at the beginning of the tracking system motion data, which may reflect the learning time of the internal tumour position estimator (figure 1(b)). (3) Large time intervals (more than 5 s) where no data were recorded, which may indicate that the treatment was stopped or paused, problems with the external imaging occurred or the system might be unable to track the fiducials (e.g., maybe something was in the way of the tracking beam) (figure 1(c)). (4) Data points showing the large motion change in one direction only out of three directions because there possibly were large changes in couch motion, or fiducials were mistracked or not tracked ( figure 2(a) ). Note that data points showing the large motion changes in two directions simultaneously while maintaining the motion in the third direction were included (figure 2(b)).
Separation of individual respiratory cycles
The starting point in analysing the respiratory tumour motion data begins with breaking the data into individual respiratory cycles to obtain the information on motion, such as a respiratory-induced peak-to-trough distance and period. First of all, the system noise was removed by filtering the tracking system motion data using the first-order Butterworth lowpass filter with a cut-off frequency of 2.5 Hz, assuming that anything greater than ten times average respiratory frequency (∼0.25 Hz) (Seppenwoolde et al 2002 , George et al 2005 was noise or due to sources other than respiration. High-frequency noise was also evident in the data. To separate individual respiratory cycles, 3D tumour motion, R = √ LR 2 + AP 2 + SI 2 , where LR was motion in the left-right (LR) direction, AP in the anterior-posterior (AP) direction and SI in the superior-inferior (SI) direction, was calculated. This approach is more reasonable than using either LR, AP or SI motion, since the correlation coefficients between any two of them are not always one. Before calculating R, a new coordinate system was determined in which the correlations between each two motion directions were positive and the minimum values of LR, AP and SI motion corresponded to zero. The motion data in each direction were then moved to a new coordinate system where inhalation corresponded to maximum R and exhalation to minimum R, and all motion was positive. Then, the respiratory-induced peak-to-trough distance and period were determined as follows.
(1) Generating smoothed data and a moving average baseline from the filtered tracking system motion data. In figure 3 (a), the black solid curve is the filtered tracking system motion data versus time and the blue dashed curve is the smoothed data versus time. The smoothed data were created by smoothing the filtered tracking system data (recorded 25 times per second) with the moving average of 25 points that correspond to 1 s (∼minimum period of patient free breathing). This idea is from Seppenwoolde et al (2002) and Neicu et al (2003) , where the raw data (recorded 30 times per second) were filtered with the 30-point median filter. The red dot-dashed curve is a moving average baseline versus time (figure 3(a)), which was created by smoothing the filtered tracking system data with the moving average of 200 points that correspond to 8 s (∼double the mean period of patient free breathing) (Lu et al 2006) . (2) Searching intersections between the two curves. To find intersections of the smoothed data (blue dashed curve) and the moving average baseline (red dot-dashed curve), the differences between them were calculated. By using the signs of displacement differences, intersections of the blue dashed and red dot-dashed curves were found (circled in figure 3 (b)). (3) Determining peaks and troughs between the intersections. Once intersections were found, peaks (triangles) as maximum points and troughs (inverted triangles) as minimum points were determined between adjacent intersections (circles), as shown in figure 3(b). When searching peaks and troughs, only time intervals of more than 0.4 s from a peak to a trough
Figure 3. Separation of individual respiratory cycles: (a) the black solid curve represents the filtered tracking system motion data, the blue dashed curve represents the smoothed data and the red dot-dashed curve represents a moving average baseline; (b) the circles mark intersections between the blue dashed and red dot-dashed curves, and the triangles and inverted triangles represent peak and trough points, which are the maximum and minimum points between adjacent intersections, respectively.
or from a trough to a peak were accepted, assuming that the patient minimum breathing period was around 0.8 s. Otherwise, the peaks and troughs were ignored because they were considered not to be real peaks or troughs, but instead they were regarded as errors, such as small bumps or unremoved noise. This minimum breathing period is based on the patient population data from George et al (2005) , who stated that the mean period for free breathing was 3.8 s and that the fifth percentile of the variations of this period was 2.13 s (i.e. twice the SD from the mean). Extrapolating 3 SD from the mean gave 0.8 s or 0.4 s for each of inhalation and exhalation. Varying this value from 0.4 s to either 0.3 or 0.5 s had little impact on the overall results, which indicated moderate insensitivity to the choice of parameter values. If more than one maximum or one minimum point existed between adjacent intersections (same y values, but different x values in the figure 3 plots), the time values were averaged to minimize the effect on calculating the respiratory period. (4) Calculating peak-to-trough distance and period. The respiratory-induced peak-to-trough distance was calculated as the displacement difference between the consecutive peak and trough points and the respiratory period as the time difference from one peak to the next peak.
Analysis of respiratory motion data
Once separated into individual respiratory cycles, the patient tumour motion data were analysed to obtain useful information on respiratory tumour motion for large patient population data. The data analysed in this study were as follows: (1) respiratory-induced peak-to-trough distance, (2) respiratory period, (3) per cent contributions to 3D motion (R) from motion in the LR, AP and SI directions and (4) motion nonlinearity and hysteresis. Tumour motion hysteresis occurs when a tumour follows different paths between inhale and exhale phases during a respiratory cycle (Seppenwoolde et al 2002 , Manke et al 2003 , Mageras et al 2004 , Blackall et al 2006 , Wolthaus et al 2006 , Boldea et al 2007 , Mori et al 2007 . Nonlinearity and hysteresis of patient tumour motion were quantified using principal component analysis (PCA). The first principal component that PCA generates is a single axis in space. When each data point is projected on that axis, the resulting values form a new variable, and the variance of this new variable is the maximum among all possible choices of the first axis (Jackson 1991 , Wall et al 2003 . The first principal component was expressed as a normalized percentage (ranging from 33% to 100%), where 100% indicated pure linear motion, and the lower the percentage, the more nonlinear motion and/or more hysteresis. For each of 143 treatment fractions, the first principal components of individual respiratory cycles were calculated.
Results

Creation of a database of patient tumour motion
Extracted motion data are the longest single contiguous data set selected for each of 143 treatment fractions. The mean duration time of the extracted data is 30 min, ranging from 5 to 86 min, and the total duration time is approximately 72 h. The mean ratio of duration time in the tracking system motion data and that in the extracted motion data is 0.42, and ranges from 0.07 to 0.99.
Separation of individual respiratory cycles
Figure 4 illustrates typical respiratory tumour motion, where the algorithm correctly determines peaks and troughs. By using the smoothed data and the moving average baseline, even very irregular respiratory tumour motion is correctly separated into individual cycles. The algorithm successfully separates the respiratory traces with significant fluctuations (figure 4(c)), considerable noise (figures 4(d) and (e)) or a large peak (figure 4(f)) into individual respiratory cycles. However, there are some cases where the algorithm fails to determine correct peaks or troughs, as shown in figure 5. When there are repeated very small peaks and troughs (figure 5(a)) or very fast respiratory cycles ( figure 5(b) ), the algorithm fails to separate the motion data into individual cycles correctly.
Using the intersections of the smoothed curves and the moving average baseline curves alone, 70 696 individual respiratory cycles are detected for all treatment fractions analysed. By enforcing the minimum 0.4 s peak-to-trough or trough-to-peak rule, 478 cycles are removed, leaving 70 218 cycles for further analyses. Included in the final respiratory cycles are three cycles with negative peak-to-trough distances, as well as 27 cycles with a trough-to-peak time of less than 0.4 s, despite shorter cycles being removed by the previous rule. These are explained by the design of an algorithm used to separate the tumour motion into individual cycles. The algorithm initializes from a peak and locates the following trough and peak. Only when the time intervals between the initial peak and trough and between the trough and the next peak are more than 0.4 s, the algorithm accepts the initial peak and the trough as a pair.
Analysis of respiratory motion data
The overall mean respiratory-induced peak-to-trough distance is 0.48 cm, with individual treatment fraction means ranging from 0.02 to 1.44 cm. The overall mean respiratory period is 3.8 s, with individual treatment fraction means ranging from 2.2 to 6.4 s. The mean of the individual treatment fraction SDs for the peak-to-trough distance and period is 0.15 cm (0.01-0.73) and 0.8 s (0.2-1.7), respectively. Detailed statistics are given in appendix A. Tables 1 and 2 show the mean of individual treatment fraction means and SDs for the peak-to-trough distance and respiratory period for each of 30 lung and 12 retroperitoneal tumour patients, respectively. On average, the peak-to-trough distance is slightly larger for
Figure 4. Examples of respiratory tumour motion where the algorithm correctly determines peaks and troughs and thus separates the motion data into individual cycles despite significant respiratory irregularity: typical respiratory tumour motion ((a) and (b)), irregular motion, which represents the respiratory traces with (c) significant fluctuations, (d) and (e) considerable noise and (f) a large peak. The black solid curve is the filtered tracking system motion data, the blue dashed curve is the smoothed data and the red dot-dashed curve is a moving average baseline. The triangles and inverted triangles are peak and trough points, respectively. lung tumours, while the period is slightly longer for retroperitoneal tumours. However, the differences of the peak-to-trough distance and period between lung and retroperitoneal tumours are not significant; rather these vary from patient to patient, as shown in figures 6(a) and (b).
(a) (b) Figure 5 . Examples of respiratory tumour motion where the algorithm fails to separate the motion data into individual cycles correctly: the respiratory traces with (a) repeated small peaks and troughs and (b) fast respiratory cycles. The black solid curve is the filtered tracking system motion data, the blue dashed curve is the smoothed data and the red dot-dashed curve is a moving average baseline. The triangles and inverted triangles are peak and trough points, respectively. Table 3 shows patient tumour motion data sorted by motion extent. Out of 143 treatment fractions, 57 show the mean peak-to-trough distance to be greater than 0.5 cm (40%): 44 treatment fractions (42% of all lung tumour fractions) from 16 lung tumour patients and 13 fractions (34% of all retroperitoneal tumour fractions) from 7 retroperitoneal patients. The mean of individual fraction means for the peak-to-trough distance for lung and retroperitoneal tumours is 0.81 cm and 0.74 cm, respectively, for motion greater than 0.5 cm, and 0.28 cm and 0.27 cm, respectively, for motion less than/equal to 0.5 cm. The lung tumours are sorted to seven different tumour locations in the lungs, as shown in table 4. As expected, tumours in the lower lobes of the lungs show more motion than those in the upper lobes.
The respiratory period, however, does not show any trends dependent on motion extent or tumour sites. The longest mean period (6.1 s) occurs in a retroperitoneal tumour patient, whose three treatment fractions are the top three individual treatment fraction means for the respiratory period (6.4, 6.3 and 5.8 s) (table 2). The second and third longest mean periods are from lung tumour patients (5.2 and 5.1 s) (table 1). The details for tables 1-3 are given in appendices B and C.
Figure 6(c) shows the mean per cent contributions to 3D motion (R) from motion in the LR, AP and SI directions for each of 30 lung and 12 retroperitoneal tumour patients. Out of 143 treatment fractions, 26 fractions (18%) show the dominant RL motion, 32 fractions (22%) show the dominant AP motion and 85 fractions (60%) show the dominant SI motion. The per cent contributions do not show any trends dependent on motion extent or tumour sites. The RL motion is dominant in 16% of 105 lung tumour treatment fractions, the AP motion is in 27% and the SI motion is in 57%. For 38 retroperitoneal treatment fractions, the RL motion is dominant in 24% of the fractions, the AP motion is in 10% and the SI motion is in 66%. For all 143 treatment fractions, the individual treatment fraction means for per cent contributions from the LR, AP and SI motion range 3-73%, 8-84% and 5-77%, respectively. There are no noticeable differences between the lung and retroperitoneal tumours in terms of per cent contribution. The individual treatment fraction means for lung tumours range 3-73% in the LR motion, 8-67% in the AP motion and 5-77% in the SI motion, and those Table 1 . Tumour motion data for each of 30 lung tumour patients: the mean of individual treatment fraction means and standard deviations (SD) for the peak-to-trough distance and period. Note that patients 5 and 27 included more than one tumour sites.
Number of Peak-to-trough distance (cm) Period ( for retroperitoneal tumours range 7-64% in the LR motion, 11-84% in the AP motion and 5-69% in the SI motion. Figure 6 (d) shows the mean and SD of the first principal component (normalized percentage) showing motion nonlinearity and hysteresis for each treatment fraction. The overall mean of the first principal component for all treatment fractions is 94%, with individual treatment fraction means ranging from 69% to 100%. The overall mean and range of the first principal component for lung and retroperitoneal tumours are 93% (69-100) and 98% (85-100), respectively. Only seven treatment fractions out of 143 (5%) have the means of the first principal component less than 80%, all of which are from four lung tumour patients. On the other hand, 89 treatment fractions (62%) have the means of the first principal component greater than 95%. These are from 56 treatment fractions (53% of all lung tumour Table 2 . Tumour motion data for each of 12 retroperitoneal tumour patients: the mean of individual treatment fraction means and standard deviations (SD) for the peak-to-trough distance and period.
Number of Peak-to-trough distance (cm) Period ( 0.50 ± 0.14 6.1 ± 1.3 Total 38 0.44 ± 0.14 4.1 ± 0.8 Table 3 . Tumour motion data sorted by motion extent (greater than 0.5 cm or less than/equal to 0.5 cm): the mean of individual treatment fraction means and standard deviations (SD) for the peak-to-trough distance and period. There are 44 treatment fractions from 16 lung patients and 13 treatment fractions from 7 retroperitoneal patients whose mean peak-to-trough distance is greater than 0.5 cm.
Peak-to-trough distance (cm) Period (s) Mean ± SD Mean ± SD Lungs >0.5 cm 0.81 ± 0.24 3.7 ± 0.8 0.5 cm 0.28 ± 0.10 3.6 ± 0.8 Retroperitoneum >0.5 cm 0.74 ± 0.22 4.4 ± 0.9 0.5 cm 0.27 ± 0.09 4.0 ± 0.7 Table 4 . Tumour motion data sorted by tumour sites in the lungs with the number of treatment fractions: the mean of individual treatment fraction means and standard deviations (SD) for the peak-to-trough distance and period.
Peak-to-trough distance (cm) Period (s) Mean ± SD Mean ± SD Left lower lobe (10) 0.73 ± 0.23 3.7 ± 0.7 Left upper lobe (35) 0.36 ± 0.15 3.7 ± 0.8 Right lower lobe (15) 0.87 ± 0.18 3.1 ± 0.6 Right middle lobe (13) 0.36 ± 0.12 3.7 ± 0.7 Right upper lobe (15) 0.39 ± 0.16 3.5 ± 0.7 Hilum (15) 0.54 ± 0.13 4.1 ± 0.9 Others (2) 0.62 ± 0.18 4.7 ± 0.9 fractions) from 22 lung tumour patients and 33 fractions (87% of all retroperitoneal tumour fractions) from 11 retroperitoneal patients. Figure 7 shows the examples of motion nonlinearity and hysteresis during individual respiratory cycles. The normalized percentages of the first principal component are 100% for linear tumour motion with no hysteresis (figure 7(a)), 97% for nonlinear tumour motion with no hysteresis (figure 7(b)), and between 95% and 69% for tumour motion with hysteresis (figures 7(c)-(f)). 
Discussion
The respiratory-induced tumour motion estimated from the correlation between the external and internal motion for a large patient population over long time periods was analysed and characterized. The algorithm to separate individual respiratory cycles is similar to that presented by Lu et al (2006) , which makes use of moving average curves to identify the intersections. Similar to their conclusions, this study shows that using the moving average curves instead of the derivatives can remove the effect of possible signal drift and noise.
Lu et al showed a 99% success rate in detection of the extremes, but this only represents 307 peaks and troughs. In this study, 70 218 respiratory cycles were examined after separating individual cycles and used to further characterize respiratory tumour motion. The algorithm worked well, even for the significant irregularity of respiratory tumour motion (figure 4); however, it failed in some cases (figure 5), which indicated that separating the individual cycles is a complex problem. Due to substantial temporal changes in respiratory tumour motion, developing a robust algorithm to separate the individual respiratory cycles is challenging. The AAPM Task Group 76 (Keall et al 2006) summarized lung tumour motion and showed that the greatest lung tumour motion is generally in the SI direction, whereas the least motion is in the LR direction. The lung tumour motion tends to increase from the upper lobes to the lower lobes. The maximum extent of the motion documented was 5 cm (Chen et al 2001) . Ekberg et al (1998) showed relatively small motion in which the mean extent was 0.4 cm at the most, while Erridge et al (2003) reported relatively large motion with the mean extent being 1.3 cm in the SI direction. In our study, the mean extent of lung tumour motion is 0.50 cm (0.02-1.44) (appendix B), which is comparable to that reported in the literature. As shown in table 4, the mean extent of lung tumour motion in the lower lobes is more than twice as much as that in the middle and upper lobes. The mean tumour motion extent in the hilum is 0.54 cm, which is between that in the middle/upper lobes and that in the lower lobes (table 4) .
For retroperitoneal tumour motion, two older studies showed similar extent of motion in which the mean was 2 cm (1-3) from a large patient population (36 subjects (Bryan et al 1984) and 50 subjects (Suramo et al 1984) ). The mean extent of retroperitoneal tumour motion observed in our study (38 treatment fractions for 12 patients) is 0.44 cm (0.03-0.98) (appendix B). This result is somewhat smaller than the observations made in the older studies mentioned above; however, it is comparable to a more recent published study by Gierga et al (2004) that reported the mean tumour motion of 0.7 cm in the SI direction and 0.4 cm in the AP direction.
Three studies included the period of respiratory motion: one reported 16 5-min respiratory tumour motion traces for each of 20 lung cancer patients (Seppenwoolde et al 2002) that showed that the mean period was 3.6 ± 0.8 s (SD). George et al (2005) reported that the mean period was 3.8 ± 1.1 s (SD) from 331 4-min respiratory motion traces for 24 free-breathing lung cancer patients. Lu et al (2006) showed that the respiratory waveforms (575.3 s long) for 20 thoracic or upper abdominal cancer patients resulted in the mean respiratory period of 4.1 ± 0.9 s (SD). The overall mean respiratory period of lung tumour in our study is 3.7 ± 0.8 s (SD), which is comparable to that cited in the literature. Unlike the peak-to-trough distance, the respiratory period does not show any trends that are dependent on the location of tumour sites in the lungs; instead, they are similar to one another, with individual treatment fraction means ranging from 2.2 to 5.6 s (table 4).
The signal complexity and non-stationarity of respiratory tumour motion result in a phase difference in the motion in each of the three directions. Thus, the correlation coefficients between tumour motion in any two directions are not one. This shows that the respiratory period resulting from each of the three directions may be different from one another if the tumour motion is treated separately in the LR, AP and SI directions. To avoid ambiguity, the period was computed from the 3D motion vector. Therefore, this study presents the 3D extent of tumour motion (R), while most studies tend to report tumour motion along the separate 1D components of direction (LR, AP and SI motion) .
Still, the per cent contributions to 3D motion (R) from the motion extent in each of the three directions are important, and so they are also presented in this study. A recent study by Britton et al (2007) showed that tumour motion from the 4D computed tomography (4D CT) data sets was mostly in the SI direction. The findings of Britton et al are also consistent with data presented in the other literature in which the greatest respiratory tumour motion was in the SI direction.
Likewise in our study, the mean per cent contribution to 3D motion from the SI motion is the greatest in 85 out of 143 treatment fractions (60%) when compared to the AP (22%) and LR (18%) motion, which is the smallest. However, the ranges of individual treatment fraction means for three motion directions are similar (from 5% to 75%), and show the large individual variations in the directions and extent of motion. Although it is true that respiratory tumour motion is generally the greatest in the SI direction, some patient treatment fractions show predominate motion in the LR or AP direction, as shown in figure 6(c).
These findings were discussed in a previous work using the same tumour motion data (Suh et al 2007) , where substantial patient-to-patient respiratory tumour motion variation was observed.
One of the conditions where the respiratory management techniques should be considered in regard to the recommendations made by the AAPM Task Group 76 (Keall et al 2006) is when the tumour motion range in any direction is greater than 0.5 cm. Thus, tumour motion data are sorted by the motion extent that is either greater than 0.5 cm or less than/equal to 0.5 cm, as shown in table 3. Fifty-seven (57) treatment fractions out of 143 show motion extent greater than 0.5 cm, with the mean of individual treatment fraction means for the peakto-trough distance being 0.81 cm for lung tumours and 0.74 cm for retroperitoneal tumours (table 3) . Again, the means of the respiratory period are similar between the motion extent greater than 0.5 cm and that less than/equal to 0.5 cm.
The motion nonlinearity and hysteresis are important characteristics of respiratory tumour motion, but no consensus on how to quantify their extent has been reached. Seppenwoolde et al (2002) calculated the hysteresis as a phase difference between the fitted parameterized curves of the average breathing cycles of two directions. From 3D tumour trajectories, they showed that the hysteresis ranged from 0.1 to 0.5 cm for 10 out of 21 tumours. Based on these findings, Seppenwoolde et al concluded that the extent of hysteresis remained rather constant during the treatment. In our study, PCA is used to quantify the motion nonlinearity and hysteresis. Another application of PCA in radiotherapy includes quantification of the variability in a data set of dose-volume histograms (Dawson et al 2005 , Bauer et al 2006 , Skala et al 2007 , Sohn et al 2007 . Figure 7 shows the motion nonlinearity and hysteresis of individual respiratory cycles with the corresponding first principal components of PCA. As the normalized percentages of the first principal components become smaller, the motion nonlinearity and hysteresis increase. The two paths of tumour, one from exhale to inhale and the other from inhale to exhale, are often quite different and show motion hysteresis. Given that for many of the treatment fractions the means of the first principal component are greater than 90%, the motion nonlinearity and hysteresis usually are not significant; however, they are not negligible, either. PCA can be used to separate nonlinear and hysteresis motion from linear motion, but it cannot be used to differentiate between motion nonlinearity and hysteresis, which is one weakness in using this method.
Conclusions
The analysis and characterization of patient respiratory tumour motion were performed using more than 70 h of tumour motion data for 143 treatment fractions in 42 stereotactic body radiotherapy patients. Individual treatment fraction means of tumour motion ranged from 0.02 to 1.44 cm and were greater than 0.5 cm in 57 (40%) of the treatment fractions. Generally, tumour motion was predominantly SI (60% of all the treatment fractions) while predominant AP and LR motion being 22% and 18%, respectively. The motion was predominantly linear, with the overall mean of the first principal component being 94%. However, for motion magnitude, direction and linearity, large variations were observed from patient to patient, fraction to fraction and cycle to cycle. Beyond the quantification and analysis of the tumour motion, there are a number of ongoing uses of this data set, including the use of monoscopic imaging to quantify motion (Suh et al 2007) , along with the development and continuing investigations of motion prediction. In addition to this ongoing work, there are many further potential applications of the data. For investigators wishing to pursue novel applications of the data, it is available from one of the authors, Sonja Dieterich, by request. 
Appendix C
Tumour motion data of lung and retroperitoneal tumour patients sorted by motion extent (greater than 0.5 cm or less than/equal to 0.5 cm): mean and range of individual treatment fraction means, standard deviations (SD), maximums (max), minimums (min) and root mean squares (RMS) for the peak-to-trough distance and period (details for table 3). 
